CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease

American Journal of Pathology

Volumn 174, Issue 5, 2009, Pages 1725-1734

  Riser, Bruce L ^a,b,f   Najmabadi, Feridoon ^a   Perbal, Bernard ^c   Peterson, Darryl R ^a   Rambow, Jo Ann ^a   Riser, Melisa L ^a   Sukowski, Ernest ^a   Yeger, Herman ^d,e   Riser, Sarah C ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c University of Paris   (France)

^d UNIVERSITY OF TORONTO   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; GROWTH FACTOR; MESSENGER RNA; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CTGF PROTEIN, RAT; LUCIFERASE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; KIDNEY DISEASE; KIDNEY FIBROSIS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSIS; FISCHER 344 RAT; GENETICS; HUMAN; IN VITRO STUDY; MESANGIUM; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROSIS; GLOMERULAR MESANGIUM; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY DISEASES; LUCIFERASES; MICE; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; PROMOTER REGIONS, GENETIC; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 65649136944     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080241     Document Type: Article

References (37)

1. Brigstock DR, Goldschmeding R, Katsube KI, Lam SC, Lau LF, Lyons K, Naus C, Perbal B, Riser B, Takigawa M, Yeger H: Proposal for a unified CCN nomenclature. Mol Pathol 2003, 56:127-128 (Pubitemid 36461474)
2. Perbal B: CCN proteins: multifunctional signalling regulators. Lancet 2004, 363:62-64 (Pubitemid 38076928)
3. Perbal B: The CCN family of genes: a brief history. Mol Pathol 2001, 54:103-104 (Pubitemid 32270003)
4. Rachfal AW, Brigstock DR: Structural and functional properties of CCN proteins. Vitam Horm 2005, 70:69-103
5. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Narins RG: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000, 11:25-38 (Pubitemid 30020423)
6. Bollineni JS, Reddi AS: Transforming growth factor-beta 1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 1993, 42:1673-1677 (Pubitemid 23318126)
7. Ziyadeh FN: Mediators of diabetic renal disease: the case for TGF-β as the major mediator. J Am Soc Nephrol 2004, 15:S55-S57 (Pubitemid 38018457)
8. Hahn A, Heusinger-Ribeiro J, Lanz T, Zenkel S, Goppelt-Struebe M: Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton. J Biol Chem 2000, 275:37429-37435
9. Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa M, Sugawara A, Nakao K: Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 2004, 15:1430-1440 (Pubitemid 38679668)
10. Okada H, Kikuta T, Kobayashi T, Inoue T, Kanno Y, Takigawa M, Sugaya T, Kopp JB, Suzuki H: Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis. J Am Soc Nephrol 2005, 16:133-143 (Pubitemid 43073165)
11. Guha M, Xu ZG, Tung D, Lanting L, Natarajan R: Specific downregulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes. FASEB J 2007, 21:3355-3368 (Pubitemid 47565554)
12. McCallum L, Price S, Planque N, Perbal B, Pierce A, Whetton AD, Irvine AE: A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood 2006, 108:1716-1723 (Pubitemid 44316142)
13. Li CL, Martinez V, He B, Lombet A, Perbal B: A role for CCN3 (NOV) in calcium signalling. Mol Pathol 2002, 55:250-261
14. Kyurkchiev S, Yeger H, Bleau AM, Perbal B: Potential cellular conformations of the CCN3(NOV) protein. Cell Commun Signal 2004, 2:9
15. Riser BL, Cortes P, Yee J, Sharba AK, Asano K, Rodriguez-Barbero A, Narins RG: Mechanical strain- and high glucose-induced alterations in mesangial cell collagen metabolism: role of TGF-beta. J Am Soc Nephrol 1998, 9:827-836 (Pubitemid 28209092)
16. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN, Perbal B: novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol 1998, 152:1563-1575 (Pubitemid 28275014)
17. Poncelet AC, de Caestecker MP, Schnaper HW: The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 1999, 56:1354-1365 (Pubitemid 29451243)
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159 (Pubitemid 17064313)
19. Cooker LA, Peterson D, Rambow J, Riser ML, Riser RE, Najmabadi F, Brigstock D, Riser BL: TNF-{alpha}, but not IFN-{gamma}, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. Am J Physiol 2007, 293:F157-F165 (Pubitemid 47345014)
20. Riser BL, Cortes P, Yee J: Modelling the effects of vascular stress in mesangial cells. Curr Opin Nephrol Hypertens 2000, 9:43-47 (Pubitemid 30041746)
21. Riser BL, Cortes P: Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis. Ren Fail 2001, 23:459-470 (Pubitemid 32692281)
22. Riser B, Foroni A, Karoor S: CCN2 (CTGF) in the Pathogenesis of Diabetic Renal Disease: A Target for Therapeutic Intervention. Edited by Morgensen C, Cortes P. Boston, Kluwer Academic Publishers, 2006
23. Abdel-Wahab N, Weston BS, Roberts T, Mason RM: Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J Am Soc Nephrol 2002, 13:2437-2445
24. Thomopoulos GN, Kyurkchiev S, Perbal B: Immunocytochemical localization of NOVH protein and ultrastructural characteristics of NCIH295R cells. J Submicrosc Cytol Pathol 2001, 33:251-260 (Pubitemid 33760000)
25. Ball DK, Moussad EE, Rageh MA, Kemper SA, Brigstock DR: Establishment of a recombinant expression system for connective tissue growth factor (CTGF) that models CTGF processing in utero. Reproduction 2003, 125:271-284 (Pubitemid 36284899)
26. Parisi MS, Gazzerro E, Rydziel S, Canalis E: Expression and regulation of CCN genes in murine osteoblasts. Bone 2006, 38:671-677
27. Lafont J, Laurent M, Thibout H, Lallemand F, Le Bouc Y, Atfi A, Martinerie C: The expression of novH in adrenocortical cells is downregulated by TGFbeta 1 through c-Jun in a Smad-independent manner. J Biol Chem 2002, 277:41220-41229 (Pubitemid 35215714)
28. Liu C, Liu X-J, Crowe PD, Kelner GS, Fan J, Barry G, Manu F, Ling N, De Souza EB, Maki RA: Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation. Gene 1999, 238:471-478 (Pubitemid 29446181)
29. Niu Z, Ito M, Awakura Y, Takahashi T, Nakamura E, Ito N, Ogawa O: The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. J Urol 2005, 174:1460-1462 (Pubitemid 41318764)
30. Glukhova L, Angevin E, Lavialle C, Cadot B, Terrier-Lacombe M-J, Perbal B, Bernheim A, Goguel A-F: Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas. Cancer Genet Cytogenet 2001, 130:105-110 (Pubitemid 33033226)
31. Gupta R, Hong D, Iborra F, Sarno S, Enver T: NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells. Science 2007, 316:590-593 (Pubitemid 46683143)
32. van Roeyen CR, Eitner F, Scholl T, Boor P, Kunter U, Planque N, Grone HJ, Bleau AM, Perbal B, Ostendorf T, Floege J: CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation. Kidney Int 2008, 73:86-94 (Pubitemid 350273638)
33. Hostetter TH: Progression of renal disease and renal hypertrophy. Annu Rev Physiol 1995, 57:263-278
34. Lassila M, Jandeleit-Dahm K, Seah KK, Smith CM, Calkin AC, Allen TJ, Cooper ME: Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. J Am Soc Nephrol 2005, 16:363-373 (Pubitemid 41725131)
35. Chow FY, Nikolic-Paterson DJ, Atkins RC, Tesch GH: Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant 2004, 19:2987-2996 (Pubitemid 40057619)
36. Uehara G, Suzuki D, Toyoda M, Umezono T, Sakai H: Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy. Clin Exp Nephrol 2004, 8:36-42
37. Phanish MK, Wahab NA, Colville-Nash P, Hendry BM, Dockrell ME: The differential role of Smad2 and Smad3 in the regulation of profibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J 2006, 393:601-607 (Pubitemid 43099100)